330 likes | 479 Views
Chronic Stress and Distress of Mothers of Children with Acute Lymphocytic Leukemia During Maintenance Therapy. Madalynn Neu, PhD, RN Ellyn Matthews, PhD, RN Paul Cook, PhD. Acknowledgments.
E N D
Chronic Stress and Distress of Mothers of Children with Acute Lymphocytic Leukemia During Maintenance Therapy Madalynn Neu, PhD, RN Ellyn Matthews, PhD, RN Paul Cook, PhD
Acknowledgments • This research is supported by the UCDenver Colorado Clinical Translational Science Institute (CCTSI) Pilot Award (1UL1RR014780) and Clinical Translational Research Center (CTRC) Funding for cortisol assays, bioinformatics, nursing support • We would like to acknowledge the contributions of the research team: • Flori Legette • Kimberlee Horst • Nancy Kipke • Nancy Waas • Ken Clevenger • Erin Hughes • Megan Duffy • Mark Laudenslager, PhD • Tim Garrington, MD • Martin Reite, MD • Paul Cook, PhD • Janie Kappius • Ann Ribe • Jane Ambro • Lacey Felmlee
ALL Background Most common malignancy in childhood; accounts for 75% of all childhood leukemias (AML 23%, CML 2%) 3000 new cases annually in U.S. Peak incidence is 4 years of age Overall survival of 70-80%, approaches 90% for standard or low risk patients Age: >1 and <10 yo is favorable WBC: <50,000 is favorable
ALL Treatment Induction: Goal is remission- 4wks Consolidation: Treatment to spine - 4-8 wks Interim Maintenance: Rest phase- 6-8 wks Delayed Intensification: Reduces # of hiding cells- 8 wks Maintenance: 2 years for females 3 years for males
Maintenance Chemotherapy Dexamethasone orally 5 days every 4 weeks Vincristine IV every 4 weeks Mercaptopurine orally daily x 84 days Oral methotrexate weekly Intrathecal methotrexate every 12 weeks
Potential side effects Steroids: increased appetite, weight gain, fluid retention, mood swings Vincristine: body aches, peripheral neuropathy Mercaptopurine: nausea, low blood counts Methotrexate: nausea, low blood counts
Operational Definitions of Stress and Distress • Stress • Activation of HPA axis indicated by cortisol levels • Self-reported stress • Distress • Anxiety • Depression
Family Disruption and Stress in Parents of Children with Cancer • Childhood cancer has been associated with disruption in family life (Aung, 2012; Gedaly-Duff et al., 2006; Sung et al., 2011; Tsimicaliset al., 2012). • Posttraumatic stress reported in ~ 25% of parents of children with cancer (Poder et al., 2008)
Stress and Distress in Parents of Children with Cancer • Decrease in parents of children with cancer from diagnosis to posttreatment • May still be present years post treatment (Best et al., 2001; Boman et al., 2003) • Occur during entire course of treatment for cancer (Norberg et al., 2005; Masa’deh et al., 2012; von Essen et al., 2004 • More severe at time of diagnosis than later during treatment (Vrijmoet-Wiersma, 2008) • More severe in complicated cancer than with ALL (Hoven et al., 2008
HPA Axis & Cortisol • Perception of stress or emotional arousal activates HPA axis • Persons experiencing chronic stress may have lower daily cortisol levels and flatter diurnal slopes (Bicanic et al., 2012; Sriram et al., 2012; van Liempt et al., 2012)
Problem • Overall survival is very good (80- 90%) in children with ALL • Research suggests that high levels of parental stress and distress decrease from time of diagnosis to post-treatment in children with cancer –but some parents continue to experience stress even after treatment is completed. • Few studies have investigated physiologic stress and emotional stress and distress in mothers of children with ALL specifically during maintenance treatment.
Overall Study Purpose • Examine the sleep/wake patterns, physiologic stress, and emotional stress and distress in mothers of children during maintenance treatment for ALL compared to matched controls • H1: Mothers of children with ALL will display greater insomnia compared to mothers of healthy children • H2: Mothers of children with ALL will display greater physiologic stress than mothers of healthy children • H3: Mothers of children with ALL will report more emotional stress and distress (anxiety, depression) than mothers of healthy children
Sampling and Study Procedures • Mothers/children with ALL • Recruited through the TCH hematology practice with the assistance of clinicians and research partners, who screened potential participants • Mothers/healthy children • Recruited from the community (ad, brochure, or university email), and matched by gender and age • Informed consent was obtained • Mothers received $40 and children received $10 or an equivalently-priced stuffed animal, disbursed at the completion of visit 2.
Maternal Inclusion and Exclusion Criteria • Inclusion • Greater than 18 years of age • Primary caregiver • Speak and write English • Exclusion • Serious, unstable physical illness • Major psychiatric disorder • Diagnosed sleep disorder • Steroid medication
Child Inclusion and Exclusion Criteria • Inclusion • Between 3 and 12 years of age • No concurrent illness or disability • Capable of consistently wearing actiwatch per mother’s assessment • ALL Only • Currently receiving maintenance treatment for ALL
Measures Demographic and Medical History Form (Adult and Child) Stress • Salivary Cortisol • Perceived Stress Scale (PSS) Psychological • Hospital Anxiety and Depression Scale (HADS) Sleep • Wrist Actigraphy • Adult and Child Sleep Diary • Insomnia Interview Schedule (Screening) • Insomnia Severity Index (ISI) • The Children’s Sleep Habits Questionnaire (CSHQ)
Salivary Cortisol • Mothers were given filter paper strips to collect saliva • Strips in booklet marked with day and time of desired collection • Mothers were asked to collect saliva On awakening 30 minutes after awakening Before eating lunch 10 hours after awakening • Mothers • Avoided eating, smoking, or drinking anything but water one hour before collection • Recorded time of last vigorous exercise, medications taken, and date of last menstrual period • Placed strip on tongue for ~ 10 sec until lower 2 inches of paper were saturated, marked the date and time of sample and air-dried the paper.
Overview of Visit 1 and 2 • Visit 1 • Consent obtained before or during visit 1 • Questionnaires administered • Education provided about salivary cortisol sampling, collection times confirmed • Actiwatches applied to non-dominant wrists (child and mother) • Education provided about the actiwatch and sleep diaries • Visit 2 (~ one week after visit 1) • Actiwatches, diaries, and saliva booklets collected • Compensation provided
Statistical Aim 1 • Area Under the Curve (AUC) AUC
Statistical Aim 1 Amount of change in cortisol per hour. • Slope • Morning rise to 30 minutes after awakening
Results: Dyad Enrollment CONTROLS Eligible (n= 29) ALL Eligible (n = 35) • 9 Refused • Reason given: • Child would not wear watch (6) • Too busy (2) • No reason given (1) • 3 Refused • Reason given: • Child would not wear watch (2) • Inadequate reimbursement (1) Completed Study: n = 26 Completed Study: n = 26
Results: Hospital Anxiety and Depression Scale (HADS) ** p .003
Results: Percent of Participants with Scores 8 and Above (cut-off) for (HADS)
Results: Salivary Cortisol AUC (n = 52) Nmol/L **p=.015
Results: Salivary Cortisol Slope (n = 52) ns
Results: Salivary Cortisol Wake to 30 Minutes (n = 52) Nmol/L ns
Discussion/Conclusion • Even in maintenance treatment, emotional distress are significantly worse in mothers of children with ALL than in matched controls • Daily cortisol levels were lower in mothers of children with ALL than in matched controls, physiologically suggesting the presence of chronic stress • Consistent with previous literature, sleep disturbance affect stress and depression levels in mothers of children with cancer, even when the chance of complete cure is very high
Limitations • The control sample was more highly educated, more employed and wealthier than the ALL sample (These potential covariates did not correlate with primary outcomes) • Sample may have been too small to detect differences in some measures • Fathers were not included in this study • Time in maintenance was variable (~1 month to close to 36 months)
Future Directions • Research • Conduct a larger study so that the effect of duration of maintenance treatment on parent stress can better be determined • Thoroughly examine the qualitative data collected in this study to determine feasibility of stress intervention for mothers/parents of children with ALL during maintenance • Include father in subsequent research • Practice • Understand that even when prognosis is very favorable and treatment is not in the intense phases, mothers of children with ALL may be experiencing stress • Encourage mothers to discuss their feelings during treatment visits